Quaker Houghton (KWR)
(Delayed Data from NYSE)
$161.60 USD
+1.57 (0.98%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $161.47 -0.13 (-0.08%) 7:58 PM ET
4-Sell of 5 4
C Value A Growth A Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$161.60 USD
+1.57 (0.98%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $161.47 -0.13 (-0.08%) 7:58 PM ET
4-Sell of 5 4
C Value A Growth A Momentum A VGM
Zacks News
Quaker Chemical (KWR) Q4 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Quaker Chemical (KWR) delivered earnings and revenue surprises of 13.93% and 6.56%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Will Higher Production Drive Newmont's (NEM) Q4 Earnings?
by Zacks Equity Research
Newmont's (NEM) fourth-quarter results are expected to reflect improved grades across a number of mines, improved gold prices and lower costs.
Celanese (CE) to Report Q4 Earnings: What's in the Offing?
by Zacks Equity Research
Softness in demand in Europe & Asia, weaker volumes and elevated energy & logistic cost are expected to have put a dent in Celanese's (CE) Q4 performance.
Ingevity (NGVT) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Ingevity (NGVT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Mosaic (MOS) to Report Q4 Earnings: What's in the Offing?
by Zacks Equity Research
Benefits of higher prices and demand for phosphate and potash are likely to reflect on Mosaic's (MOS) fourth-quarter results.
Zacks Industry Outlook Highlights Ashland, Quaker Chemical and Flexible Solutions International
by Zacks Equity Research
Ashland, Quaker Chemical and Flexible Solutions International are part of the Zacks Industry Outlook article.
3 Chemical Specialty Stocks to Watch From a Challenging Industry
by Anindya Barman
Slowing end-market demand and input cost pressure mar prospects of the Zacks Chemicals Specialty industry. ASH, KWR and FSI are set to gain from self-help actions.
Quaker Chemical (KWR) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
by Zacks Equity Research
Quaker Chemical (KWR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Agnico Eagle (AEM) to Report Q4 Earnings: What's in the Offing?
by Zacks Equity Research
Higher gold production and improved prices are likely have supported Agnico Eagle's (AEM) performance in the fourth quarter.
Teck Resources (TECK) to Report Q4 Earnings: What's in Store?
by Zacks Equity Research
Teck Resources' (TECK) Q4 results are likely to reflect low metal prices and a year-over-year drop in sales volumes for steelmaking coal, copper and zinc as well as inflated costs.
What's in Store for Piedmont Lithium (PLL) This Earnings Season?
by Zacks Equity Research
Piedmont Lithium's (PLL) fourth-quarter 2022 results are likely to reflect exploration and mine development costs as well as higher general and administrative expenses.
Barrick (GOLD) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Barrick's (GOLD) fourth-quarter results are expected to reflect the benefits of improved gold prices and strong gold production.
Will Strong Lithium Prices Drive Albemarle's (ALB) Q4 Earnings?
by Zacks Equity Research
Albemarle (ALB) is likely to have benefited from strong lithium volumes and prices and its cost-reduction actions in the fourth quarter.
Nutrien (NTR) to Report Q4 Earnings: What's in the Offing?
by Zacks Equity Research
Strong demand for potash and phosphate is expected to have driven Nutrien's (NTR) performance in Q4 amid headwinds from elevated natural gas costs.
Cleveland-Cliffs (CLF) to Post Q4 Earnings: What's in Store?
by Zacks Equity Research
Cleveland-Cliffs (CLF) is likely to have gained from strong automotive shipments and lower energy and raw material costs in Q4 amid headwinds from weaker steel prices.
CF Industries (CF) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Higher Nitrogen demand and prices are expected to have benefited CF Industries' (CF) Q4 performance.
Livent (LTHM) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Livent's (LTHM) Q4 results are likely to reflect the benefits of higher realized pricing and strong lithium demand.
DuPont (DD) Warms Up for Q4 Earnings: What's in the Cards?
by Zacks Equity Research
DuPont (DD) is likely to have benefited from strong end-market demand and its pricing and productivity actions in the fourth quarter.
FMC Corp (FMC) to Report Q4 Earnings: What's in the Offing?
by Zacks Equity Research
FMC Corp (FMC) is likely to have witnessed demand strength for its products and higher pricing in the fourth quarter amid cost and currency headwinds.
Hawkins (HWKN) Surpasses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Hawkins (HWKN) delivered earnings and revenue surprises of 4.08% and 6.48%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
U.S. Steel (X) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Weaker end-market demand, higher input costs and lower steel prices are likely to have hurt U.S. Steel's (X) fourth-quarter results.
Quaker Chemical (KWR) Moves to Strong Buy: Rationale Behind the Upgrade
by Zacks Equity Research
Quaker Chemical (KWR) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Why Quaker Chemical (KWR) Could Beat Earnings Estimates Again
by Zacks Equity Research
Quaker Chemical (KWR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Quaker Chemical (KWR) Q3 Earnings and Revenues Top Estimates
by Zacks Equity Research
Quaker Chemical (KWR) delivered earnings and revenue surprises of 21.68% and 1.88%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Ingevity (NGVT) Q3 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Ingevity (NGVT) delivered earnings and revenue surprises of 21.51% and 12.51%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?